<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Mereo BioPharma Group plc

    Mereo BioPharma Group plc

    Mereo BioPharma is a biopharmaceutical company focused on the development and comm...

    Mereo BioPharma is a biopharmaceutical company ...

    Filing Type:    PU
    Surface Oncology, Inc.

    Surface Oncology, Inc.

    Surface Oncology is an immuno-oncology company on a mission to break through and d...

    Surface Oncology is an immuno-oncology company ...

    Filing Type:    PU
    Alector, Inc.

    Alector, Inc.

    We are a clinical stage biopharmaceutical company pioneering immuno-neurology, a n...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    Inogen, Inc

    Inogen, Inc

    Inogen’s mission to improve the quality of life of supplemental oxygen users beg...

    Inogen’s mission to improve the quality of li...

    Filing Type:    PU
    Bio-Techne Corp

    Bio-Techne Corp

    Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of h...

    Bio-Techne Corporation (NASDAQ: TECH) is a lead...

    Filing Type:    PU
    Affimed Therapeutics

    Affimed Therapeutics

    At Affimed, we are committed to improving outcomes for patients with cancer. Our s...

    At Affimed, we are committed to improving outco...

    Filing Type:    PU
    Sesen Bio, Inc.

    Sesen Bio, Inc.

    At Sesen Bio, we are committed to renewing life for people with cancer. We are a l...

    At Sesen Bio, we are committed to renewing life...

    Filing Type:    PU
    Rocket Pharmaceuticals, Inc.

    Rocket Pharmaceuticals, Inc.

    Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company ...

    Rocket Pharmaceuticals, Inc. is an emerging, cl...

    Filing Type:    PU
    OptiNose, Inc.

    OptiNose, Inc.

    Optinose is a specialty pharmaceutical company focused on creating and bringing to...

    Optinose is a specialty pharmaceutical company ...

    Filing Type:    PU
    Cue Biopharma, Inc.

    Cue Biopharma, Inc.

    Cue Biopharma is an innovative clinical stage immunotherapy company developing a n...

    Cue Biopharma is an innovative clinical stage i...

    Filing Type:    PU
    NovoCure Limited

    NovoCure Limited

    Novocure is a global oncology company working to extend survival in some of the mo...

    Novocure is a global oncology company working t...

    Filing Type:    PU
    BioLineRx Ltd.

    BioLineRx Ltd.

    BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The C...

    BioLineRx is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.